MTOR and neoplasm: In addition, Torin1 (ATP competitive mTOR inhibitor) and VS-5584 (PI3K/mTOR inhibitor) can significantly reduce tumor CSC levels in a variety of human cancer transplant models (Francipane and Lagasse, 2013; Kolev et al., 2015).